The hypothalamic obesity syndrome is characterized by hyperphagia and excessive weight gain in the presence of demonstrable hypothalamic injury. There have been no previous reports describing the use of serotonergic agents in this condition. We report on a patient with severe hyperphagia and obesity
NPY-Ergic agents for the treatment of obesity
✍ Scribed by Ildikó Antal Zimányi; Graham S. Poindexter
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 239 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Severely obese subjects (n = 68) were treated in a combined behavioral modification program and monitored for a 4-year period of time. Ten subjects dropped out, and two subjects died during the study, resulting in a 18% dropout rate. The Karolinska Scales of Personality were used to compare personal
Objective: This prospective study examined whether stable personality traits, as measured by the Karolinska Scales of Personality (KSP), predicted initial weight loss or long-term maintenance in obesity patients. Method: The KSP was administered to 102 obese patients prior to entering an 8-week weig